These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 8162173
21. ATR-101, a selective ACAT1 inhibitor, decreases ACTH-stimulated cortisol concentrations in dogs with naturally occurring Cushing's syndrome. Langlois DK, Fritz MC, Schall WD, Bari Olivier N, Smedley RC, Pearson PG, Bailie MB, Hunt SW. BMC Endocr Disord; 2018 May 02; 18(1):24. PubMed ID: 29720169 [Abstract] [Full Text] [Related]
22. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation. Bertagna X, Escourolle H, Pinquier JL, Coste J, Raux-Demay MC, Perles P, Silvestre L, Luton JP, Strauch G. J Clin Endocrinol Metab; 1994 Feb 02; 78(2):375-80. PubMed ID: 8106625 [Abstract] [Full Text] [Related]
23. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease. Dickstein G, DeBold CR, Gaitan D, DeCherney GS, Jackson RV, Sheldon WR, Nicholson WE, Orth DN. J Clin Endocrinol Metab; 1996 Aug 02; 81(8):2934-41. PubMed ID: 8768855 [Abstract] [Full Text] [Related]
24. Secretion of sex hormones in dogs with adrenal dysfunction. Hill KE, Scott-Moncrieff JC, Koshko MA, Glickman LT, Glickman NW, Nelson RW, Blevins WE, Oliver JW. J Am Vet Med Assoc; 2005 Feb 15; 226(4):556-61. PubMed ID: 15742696 [Abstract] [Full Text] [Related]
25. Canine hyperadrenocorticism due to adrenocortical neoplasia. Pretreatment evaluation of 41 dogs. Reusch CE, Feldman EC. J Vet Intern Med; 1991 Feb 15; 5(1):3-10. PubMed ID: 1850483 [Abstract] [Full Text] [Related]
29. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess. Colombo P, Passini E, Re T, Faglia G, Ambrosi B. Clin Endocrinol (Oxf); 1997 Jun 15; 46(6):661-8. PubMed ID: 9274696 [Abstract] [Full Text] [Related]
30. Effects of synthetic ovine corticotropin-releasing hormone on plasma concentrations of immunoreactive adrenocorticotropin, alpha-melanocyte-stimulating hormone, and cortisol in dogs with naturally acquired adrenocortical insufficiency. Peterson ME, Kemppainen RJ, Orth DN. Am J Vet Res; 1992 Mar 15; 53(3):421-5. PubMed ID: 1317690 [Abstract] [Full Text] [Related]
36. Potentiation of the classic ovine corticotrophin releasing hormone stimulation test by the combined administration of small doses of lysine vasopressin. Favrod-Coune C, Raux-Demay MC, Proeschel MF, Bertagna X, Girard F, Luton JP. Clin Endocrinol (Oxf); 1993 Apr 15; 38(4):405-10. PubMed ID: 7686454 [Abstract] [Full Text] [Related]
37. Evaluation of a combined dexamethasone suppression/ACTH stimulation test in dogs with hyperadrenocorticism. Feldman EC. J Am Vet Med Assoc; 1985 Jul 01; 187(1):49-53. PubMed ID: 2991177 [Abstract] [Full Text] [Related]
38. Effects of corticotrophin-releasing hormone, vasopressin and insulin-like growth factor-I on proliferation of and adrenocorticotrophic hormone secretion by canine corticotrophic adenoma cells in vitro. van Wijk PA, Rijnberk A, Croughs RJ, Meij BP, Mol JA. Eur J Endocrinol; 1998 Mar 01; 138(3):309-15. PubMed ID: 9539306 [Abstract] [Full Text] [Related]